Die Debatte über eine Finanzierungsreform des deutschen Krankenversicherungssystems hat in der letzten Zeit viele Konzepte hervorgebracht. Die Vorschläge reichen von der Stabilisierung des Status quo in Form von Kopfpauschalen über die Einführung verschiedener Formen eines...

Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both on the supply and the demand side, using price,...

In all four countries health care expenditures grow while the revenue remains at the same level or even shrinks in many cases. Due to medical progress, ageing and many other factors the gap is widening over time. The pay-as-you-go approach is running against limits either with rising employer...

In all four countries health care expenditures grow while the revenue remains at the same level or even shrinks in many cases. Due to medical progress, ageing and many other factors the gap is widening over time. The pay-as-you-go approach is running against limits either with rising employer...

Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both on the supply and the demand side, using price,...

Die Debatte über eine Finanzierungsreform des deutschen Krankenversicherungssystems hat in der letzten Zeit viele Konzepte hervorgebracht. Die Vorschläge reichen von der Stabilisierung des Status quo in Form von Kopfpauschalen über die Einführung verschiedener Formen eines...